News & Updates
Filter by Specialty:
Olanzapine vs fosaprepitant: Which is better for CINV prevention?
Olanzapine appears to be just as effective as fosaprepitant, a neurokinin-1 receptor antagonist (NK1-RA), in controlling chemotherapy-induced nausea and vomiting (CINV) in patients with gynaecologic malignancies who were receiving carboplatin/paclitaxel chemotherapy every 3 weeks, a prospective study presented at SGO 2024 suggests. However, the former trumps the latter in terms of cost effectiveness.
Olanzapine vs fosaprepitant: Which is better for CINV prevention?
09 May 2024
Are dietary interventions better than meds for IBS?
Making certain dietary changes may have a larger impact than taking medications in terms of quelling the symptoms of irritable bowel syndrome (IBS) for patients with moderate-to-severe disease.
Are dietary interventions better than meds for IBS?
02 May 2024
Do IBD patients have a need for mental health care?
A recent study suggests greater focus must be given on depression or anxiety symptoms than an actual diagnosis of these psychological disorders in predicting who among people with inflammatory bowel disease (IBD) will have a need for mental health care.
